JPRN-UMIN000014759已完成未知
A Prospective, Multi-center, Three Year Follow-up Study on Endovascular Treatment for Infra-inguinal Vessel in patients with critical limb ischemia. - OLIVE 3year follow-up study
OLIVE Registry Study Group0 个研究点目标入组 229 人开始时间: 2014年8月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 229
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who dose not give informed consent.
研究者
相似试验
进行中（未招募）
1 期
A 3-year follow-up study in chronic hepatitis C patients who failed to achieve sustained virologic response during Novartis-sponsored alisporivir studiesChronic hepatitis C patients who failed to achieve sustained virologic response (SVR24) on alisporivir or direct-acting antivirals (DAA) in previous Novartis-sponsored studies.MedDRA version: 14.1Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-006132-24-GBovartis Pharma Services AG105
进行中（未招募）
不适用
A 3-year follow-up study in chronic hepatitis C patients who failed to achieve sustained virologic response during Novartis-sponsored alisporivir studiesEUCTR2011-006132-24-HUovartis Pharma Services AG650
进行中（未招募）
不适用
A 3-year follow-up study of chronic hepatitis C patients treated with alisporivir to assess durability of sustained virologic responseEUCTR2011-006131-38-GBovartis Pharma Services AG2,000
进行中（未招募）
3 期
A study to assess thedurability of sustained virologic response in Alisporivirtreatedchronic Hepatitis C patientsCTRI/2012/10/003066ovartis Healthcare Pvt Lt2,000
进行中（未招募）
不适用
A 3-year follow-up study in chronic hepatitis C patients who failed to achieve sustained virologic response during Novartis-sponsored alisporivir studiesChronic hepatitis C patients who failed to achieve sustained virologic response (SVR24) on alisporivir or direct-acting antivirals (DAA) in previous Novartis-sponsored studies.MedDRA version: 14.1Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-006132-24-ESovartis Farmaceutica, S.A.650